Victoria Socha

DocwireNews

Due to an imbalance of acid load and 
excretion, metabolic acidosis is a common complication of chronic kidney 
disease (CKD). It is possible that higher acid load is the mechanism that links 
metabolic acidosis with poor kidney outcomes, due, in part, to associations 
between higher diet-derived acid load and faster progression of CKD.The gold standard measure of acid 
load is net acid excretion (NAE). In unexpected results, higher NAE has been associated 
with slower CKD progression. Differences in NAE may reflect differences in 
diet-derived acid load in part; kidney and tubular function, body size, or 
metabolic acid production unrelated to dietary intake may also be involved.Researchers have found that the 
associations between higher NAE and slower CKD progression are particularly 
pronounced in patients with diabetes mellitus, suggesting that excess acid may 
be produced during the altered energy metabolism characteristic of diabetes and 
its precursor, metabolic syndrome. Landon Brown, MD, and colleagues 
recently conducted a cross-sectional study to explore predictors of NAE in 
patients enrolled in the CRIC (Chronic Renal Insufficiency Cohort) study. 
Results of the current analysis were reported in the American Journal of 
Kidney Diseases [2019;74(2):203-212].Candidate predictors were examined 
across a set of prespecified domains, including demographics, comorbid 
conditions, medications, laboratory values, diet, physical activity, and body 
composition. Each predictor was evaluated for an association with NAE in 
unadjusted and minimally adjusted linear regression models.Participants for the current analysis 
were randomly selected from CRIC participants with 24-hour urine samples who 
participated in the CRIC mineral metabolism substudy (n=1000). Following 
obtainment of NAE measurements, 22 participants were excluded, resulting in an 
analysis cohort of 978 participants. Mean age of the cohort was 58 years, 
56.5% were men, 40.6% were non-Hispanic whites, and 43.5% were non-Hispanic 
blacks. Mean estimated glomerular filtration rate (eGFR) was 44 mL/min/1.73 m2 
and ~51% had diabetes mellitus. Mean NAE was 33.2 mEq/d. NAE was higher among 
those with diabetes and greater levels of eGFR, insulin resistance, potential 
renal acid load (PRAL), and fat-free body mass.In unadjusted analyses, characteristics 
associated with higher NAE included non-Hispanic white race, male sex, younger 
age, larger body size, greater physical activity and dietary intake, greater 
eGFR, higher serum albumin level, history of diabetes mellitus, increasing 
insulin resistance, and use of certain metabolically active medications. Following 
multivariable adjustment for age, sex, race, eGFR, and body surface area, the 
association between higher NAE and all measures of body composition remained.There was a significant association 
between higher serum bicarbonate level and lower NAE, suggesting that low acid 
load was resulting in a higher steady-state bicarbonate concentration. There 
was no association between NAE and diuretics and other medications known to 
associate with steady-state bicarbonate concentrations. With the exception of 
metformin, there was no association between NAE and antidiabetic medications 
such as sulfonylureas, insulin, and thiazolidinediones. Within the body composition domain, 
the largest effect size was observed for fat-free mass. Within the diet domain, 
PRAL and total dietary protein had similar effect sizes. The analysis examined 
serum uric acid level as a predictor post hoc, but there was no association 
between uric acid and higher NAE in univariate analysis.To determine a full set of 
independent predictors, candidates from each of the domains were selected based 
on biologic rationale and strength of association in univariable, 
multivariable, and domain-specific models. Age, sex, race/ethnicity (non-Hispanic 
white, non-Hispanic black, and other), fat-free mass, homeostatic model 
assessment of insulin resistance, eGFR, 24-hour urine albumin excretion, 
presence of diabetes with and without use of metformin, and PRAL were included 
in the fully adjusted model.Higher NAE remained directly 
associated with non-Hispanic white race, greater fat-free body mass, greater 
eGFR, higher insulin resistance, and higher PRAL. Among participants with 
diabetes, those using metformin had higher NAE compared with those not using 
metformin (P=.03).Study limitations cited by the 
authors included the cross-sectional design; testing of urine specimens after 
long-term storage of up to 10 years, possibly affecting measurement accuracy; 
and basing urine measurements and inferences on a classic understanding of 
acid-base physiology.In conclusion, the researchers said, 
&ldquo;Overall, results from this study suggest that NAE is not only related to diet, 
but also body composition and metabolic factors, including metabolically active 
medications that could modify CKD risk. Interestingly, many of the established 
and emerging therapies that improve diabetic kidney disease outcomes also alter 
basal energy metabolism to increase acid production in diabetes mellitus. 
Metformin, a mainstay of diabetic therapy, is known to improve mortality, but 
also carries a rare risk for lactic acidosis. Newer therapies including 
sodium-glucose cotransporter 2 inhibitors also improve CKD outcomes while 
inducing subtle or frank ketosis. Sodium bicarbonate therapy may also promote 
augmented endogenous acid production, in part to protect against the 
development of metabolic acidosis, but effects on outcomes in diabetes are not 
known. We propose that differences in basal energy metabolism resulting in 
greater diet-independent acid production could explain our prior findings of 
improved kidney outcomes in diabetic patients with higher NAE and could be a 
unifying feature of kidney protective therapies in diabetes. Further studies 
are needed to validate this paradigm.&rdquo;Takeaway Points<ol class="wp-block-list">
<li>Researchers conducted an analysis of 
data from the CRIC study to examine independent predictors of net acid 
excretion (NAE) across multiple domains (demographics, comorbidities, 
medications, laboratory values, diet, physical activity, and body composition).</li>
<li>In adjusted models, there were 
associations between NAE and insulin resistance, dietary potential renal acid 
load, and a variety of metabolically active medications.</li>
<li>Higher NAE was also independently 
associated with body size, race/ethnicity, and estimated glomerular filtration 
rate.</li>
</ol>

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

CRIC Study Subanalysis: Predictors of Net Acid Excretion

Nephrology Times

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe